PHARMADVICE ApS: Financial statements 2013
CVR: 26527651
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 5,413,766 and a net result of DKK 94,188 compared with DKK -1,285 the year before. That is an increase of 58.7% compared with the year before. Equity in the 2013 report amounted to DKK 1,179,788. The solvency ratio was 45.2%.
- Gross Profit
- DKK 5,413,766
- Profit/Loss
- DKK 94,188
- Equity
- DKK 1,179,788
- Total Assets
- DKK 2,610,812
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 5.4 mio. | 94 t. | 1.2 mio. | - |
| 2012 | - | 3.4 mio. | -1 t. | 1.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMADVICE ApS has published its annual report for 2012. Gross profit came to DKK 3,411,184, and the net result was DKK -1,285.
About PHARMADVICE ApS
PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.